Accurate measurement of free carnitine in dried blood spots by isotope-dilution electrospray tandem mass spectrometry without butylation

Clinica Chimica Acta

Volumn 335, Issue 1-2, 2003, Pages 137-145

  Schulze, Andreas ^a   Schmidt, Christiane ^a   Kohlmüller, Dirk ^a   Hoffmann, Georg F ^a   Mayatepek, Ertan ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Acylcarnitines; Dried blood spots; Free carnitine; Inborn errors of metabolism; Stable isotope dilution; Tandem mass spectrometry

Indexed keywords

CARNITINE;

ACCURACY; ANALYTIC METHOD; ARTICLE; BLOOD CHEMISTRY; BUTYLATION; CATALYSIS; CHEMICAL REACTION; CONTROLLED STUDY; HUMAN; HYDROLYSIS; ISOTOPE DILUTION ASSAY; MEASUREMENT; NEWBORN; NEWBORN SCREENING; NORMAL HUMAN; PRECURSOR; PRIORITY JOURNAL; SPECTROPHOTOMETRY; TANDEM MASS SPECTROMETRY;

EID: 0242348789     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(03)00292-4     Document Type: Article

References (21)

1. Naylor E.W., Chace D.H. Automated tandem mass spectrometry for mass newborn screening for disorders in fatty acid, organic acid, and amino acid metabolism. J. Child Neurol. 14(Suppl. 1):1999;S4-S8.
2. Schulze A., Lindner M., Kohlmueller D., Olgemoeller K., Mayatepek E., Hoffmann G.F. Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry - results, outcome, and implications. Pediatrics. 11:2003;1399-1406.
3. Johnson D.W. Inaccurate measurement of free carnitine by the electrospray tandem mass spectrometry screening method for blood spots. J. Inherit. Metab. Dis. 22:1999;201-202.
4. Stevens R.D., Hillman S.L., Worthy S., Sanders D., Millington D.S. Assay for free and total carnitine in human plasma using tandem mass spectrometry. Clin. Chem. 46:2000;727-729.
5. Cederblad G., Harper P., Lindgren K. Spectrophotometry of carnitine in biological fluids and tissue with a Cobas Bio centrifugal analyzer. Clin. Chem. 32:1986;342-346.
6. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1:1986;307-310.
7. Kodo N., Millington D.S., Norwood D.L., Roe C.R. Quantitative assay of free and total carnitine using tandem mass spectrometry. Clin. Chim. Acta. 186:1990;383-390.
8. Mueller P., Schulze A., Schindler I., Ethofer T., Buehrdel P., Ceglarek U. Validation of an ESI-MS/MS screening method for acylcarnitine profiling in urine specimens of neonates, children, adolescents and adults. Clin. Chim. Acta. 327:2003;47-57.
9. Jemal M., Teitz D., Ouyang Z., Khan S. Comparison of plasma sample purification by manual liquid-liquid extraction, automated 96-well liquid-liquid extraction and automated 96-well solid-phase extraction for analysis by high-performance liquid chromatography with tandem mass spectrometry. J. Chromatogr., B, Biomed. Sci. Appl. 732:1999;501-508.
10. Hardy D.T., Preece M.A., Green A. Determination of plasma free carnitine by electrospray tandem mass spectrometry. Ann. Clin. Biochem. 38:2001;665-670.
11. Vreken P., van Lint A.E., Bootsma A.H., Overmars H., Wanders R.J., van Gennip A.H. Rapid diagnosis of organic acidemias and fatty-acid oxidation defects by quantitative electrospray tandem-MS acyl-carnitine analysis in plasma. Adv. Exp. Med. Biol. 466:1999;327-337.
12. Fingerhut R., Roschinger W., Muntau A.C.et al. Hepatic carnitine palmitoyltransferase I deficiency: acylcarnitine profiles in blood spots are highly specific. Clin. Chem. 47:2001;1763-1768.
13. Clayton P.T., Doig M., Ghafari S.et al. Screening for medium chain acyl-CoA dehydrogenase deficiency using electrospray ionisation tandem mass spectrometry. Arch. Dis. Child. 79:1998;109-115.
14. Rashed M.S., Rahbeeni Z., Ozand P.T. Screening blood spots for argininosuccinase deficiency by electrospray tandem mass spectrometry. Southeast Asian J. Trop. Med. Public Health. 30(Suppl. 2):1999;170-173.
15. Carpenter K., Wiley V., Sim K.G., Heath D., Wilcken B. Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275,000 babies. Arch. Dis. Child., Fetal Neonatal Ed. 85:2001;F105-F109.
16. Chace D.H., Hillman S.L., Van Hove J.L., Naylor E.W. Rapid diagnosis of MCAD deficiency: quantitatively analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry. Clin. Chem. 43:1997;2106-2113.
17. Pourfarzam M., Morris A., Appleton M., Craft A., Bartlett K. Neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency. Lancet. 358:2001;1063-1064.
18. Rashed M.S., Rahbeeni Z., Ozand P.T. Application of electrospray tandem mass spectrometry to neonatal screening. Semin. Perinatol. 23:1999;183-193.
19. Shigematsu Y., Hata I., Kikawa Y.et al. Modifications in electrospray tandem mass spectrometry for a neonatal-screening pilot study in Japan. J. Chromatogr., B, Biomed. Sci. Appl. 731:1999;97-103.
20. Wiley V., Carpenter K., Wilcken B. Newborn screening with tandem mass spectrometry: 12 months' experience in NSW Australia. Acta Paediatr., Suppl. 88:1999;48-51.
21. Zytkovicz T.H., Fitzgerald E.F., Marsden D.et al. Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program. Clin. Chem. 47:2001;1945-1955.